Primo Biotech Lazio is a Milan-based venture capital fund managed by Primo Capital SGR. Target of €40m, not capital already raised (source published September 2026).
Amounts come from the linked public source. A first close is not the final fund size, and a reported close does not confirm that the fund is investing now. Headquarters describe where the manager is based, not where it invests.